HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Effects of adjuvant chemotherapy on specific and non-specific immune mechanisms.

Abstract
Adjuvant chemotherapy is a well accepted concept in the treatment of breast cancer and has resulted in most clinical studies in a significant prolongation of the disease-free interval in certain subgroups of patients. However, very little is known about the late effects of adjuvant chemotherapy and its influence upon the function of a series of physiologic mechanisms. In the present paper, a review of our studies on the influence of adjuvant chemotherapy consisting of cyclophosphamide, methotrexate and fluoruracil (CMF) upon the function of B, T and natural killer (NK) cells is given. It is shown that CMF adversely influenced primary antibody production following vaccination for a prolonged period of time after the termination of CMF treatment. In investigating T cell function, it was found that the administration of CMF led also to a similarly prolonged impairment of phytohemagglutinin (PHA-)stimulated soluble interleukin 2 receptor (sIL-2R) production and to a decrease in the proliferation of peripheral blood mononuclear cells following mitogenic stimulation with PHA. Finally, NK cell activity was found to be decreased for such a prolonged period of time after the termination of CMF treatment, too. We thus conclude that the administration of CMF in the adjuvant setting leads to a pronounced and prolonged impairment of certain immune mechanisms.
AuthorsC C Zielinski, C Müller, E Kubista, A Staffen, M M Eibl
JournalActa medica Austriaca (Acta Med Austriaca) Vol. 17 Issue 1 Pg. 11-4 ( 1990) ISSN: 0303-8173 [Print] AUSTRIA
PMID2353562 (Publication Type: Journal Article)
Chemical References
  • Receptors, Interleukin-2
  • Cyclophosphamide
  • Fluorouracil
  • Methotrexate
Topics
  • Antibody Formation (drug effects)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • B-Lymphocytes (drug effects)
  • Breast Neoplasms (drug therapy, immunology, surgery)
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage, adverse effects)
  • Female
  • Fluorouracil (administration & dosage, adverse effects)
  • Follow-Up Studies
  • Humans
  • Immune Tolerance (drug effects)
  • Killer Cells, Natural (drug effects)
  • Lymphocyte Activation (drug effects)
  • Methotrexate (administration & dosage, adverse effects)
  • Receptors, Interleukin-2 (drug effects)
  • T-Lymphocytes (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: